The Key Role of Intracellular 5-HT2A Receptors: A Turning Point in Psychedelic Research?
Psychoactives October 13, 2023 J. Sapienza
Psychedelics could have revolutionary potential in psychiatry, although, until recently, the pharmacodynamic properties of such compounds have not seemed to differ much from those of serotonin, whose levels are raised by Serotonin Reuptake Inhibitors (SSRI). The cardinal point is that serotonergic compounds, such as antidepressive drugs, do not have the potential to induce long-lasting...